350 related articles for article (PubMed ID: 11305905)
21. GTP-binding-defective forms of tissue transglutaminase trigger cell death.
Datta S; Antonyak MA; Cerione RA
Biochemistry; 2007 Dec; 46(51):14819-29. PubMed ID: 18052077
[TBL] [Abstract][Full Text] [Related]
22. Regulation of transglutaminases by nitric oxide.
Bernassola F; Rossi A; Melino G
Ann N Y Acad Sci; 1999; 887():83-91. PubMed ID: 10668466
[TBL] [Abstract][Full Text] [Related]
23. Small artery remodeling depends on tissue-type transglutaminase.
Bakker EN; Buus CL; Spaan JA; Perree J; Ganga A; Rolf TM; Sorop O; Bramsen LH; Mulvany MJ; Vanbavel E
Circ Res; 2005 Jan; 96(1):119-26. PubMed ID: 15550691
[TBL] [Abstract][Full Text] [Related]
24. C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/ATPase activity.
Lai TS; Slaughter TF; Koropchak CM; Haroon ZA; Greenberg CS
J Biol Chem; 1996 Dec; 271(49):31191-5. PubMed ID: 8940119
[TBL] [Abstract][Full Text] [Related]
25. RhoA S-nitrosylation as a regulatory mechanism influencing endothelial barrier function in response to G
Chen F; Wang Y; Rafikov R; Haigh S; Zhi WB; Kumar S; Doulias PT; Rafikova O; Pillich H; Chakraborty T; Lucas R; Verin AD; Catravas JD; She JX; Black SM; Fulton DJR
Biochem Pharmacol; 2017 Mar; 127():34-45. PubMed ID: 28017778
[TBL] [Abstract][Full Text] [Related]
26. Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain.
Gaudry CA; Verderio E; Aeschlimann D; Cox A; Smith C; Griffin M
J Biol Chem; 1999 Oct; 274(43):30707-14. PubMed ID: 10521459
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of protein tyrosine phosphatases by low-molecular-weight S-nitrosothiols and S-nitrosylated human serum albumin.
Xian M; Wang K; Chen X; Hou Y; McGill A; Zhou B; Zhang ZY; Cheng JP; Wang PG
Biochem Biophys Res Commun; 2000 Feb; 268(2):310-4. PubMed ID: 10679200
[TBL] [Abstract][Full Text] [Related]
28. Impaired mitochondrial function results in increased tissue transglutaminase activity in situ.
Lesort M; Tucholski J; Zhang J; Johnson GV
J Neurochem; 2000 Nov; 75(5):1951-61. PubMed ID: 11032884
[TBL] [Abstract][Full Text] [Related]
29. Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells.
Ou H; Haendeler J; Aebly MR; Kelly LA; Cholewa BC; Koike G; Kwitek-Black A; Jacob HJ; Berk BC; Miano JM
Circ Res; 2000 Nov; 87(10):881-7. PubMed ID: 11073883
[TBL] [Abstract][Full Text] [Related]
30. Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cells.
Caputo I; Secondo A; Lepretti M; Paolella G; Auricchio S; Barone MV; Esposito C
PLoS One; 2012; 7(9):e45209. PubMed ID: 23049776
[TBL] [Abstract][Full Text] [Related]
31. S-Nitrosylation of Sarcomeric Proteins Depresses Myofilament Ca2+)Sensitivity in Intact Cardiomyocytes.
Figueiredo-Freitas C; Dulce RA; Foster MW; Liang J; Yamashita AM; Lima-Rosa FL; Thompson JW; Moseley MA; Hare JM; Nogueira L; Sorenson MM; Pinto JR
Antioxid Redox Signal; 2015 Nov; 23(13):1017-34. PubMed ID: 26421519
[TBL] [Abstract][Full Text] [Related]
32. A fluorescence anisotropy-based assay for determining the activity of tissue transglutaminase.
Hauser C; Wodtke R; Löser R; Pietsch M
Amino Acids; 2017 Mar; 49(3):567-583. PubMed ID: 26886924
[TBL] [Abstract][Full Text] [Related]
33. Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases.
Pistea A; Bakker EN; Spaan JA; Hardeman MR; van Rooijen N; VanBavel E
J Vasc Res; 2008; 45(1):10-8. PubMed ID: 17898543
[TBL] [Abstract][Full Text] [Related]
34. Involvement of tissue transglutaminase in endothelin 1-induced hypertrophy in cultured neonatal rat cardiomyocytes.
Li X; Wei XL; Meng LL; Chi MG; Yan JQ; Ma XY; Jia YS; Liang L; Yan HT; Zheng JQ
Hypertension; 2009 Oct; 54(4):839-44. PubMed ID: 19635990
[TBL] [Abstract][Full Text] [Related]
35. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner.
Tucholski J; Johnson GV
J Neurochem; 2002 May; 81(4):780-91. PubMed ID: 12065637
[TBL] [Abstract][Full Text] [Related]
36. Role of tissue transglutaminase in GTP depletion-induced apoptosis of insulin-secreting (HIT-T15) cells.
Huo J; Metz SA; Li G
Biochem Pharmacol; 2003 Jul; 66(2):213-23. PubMed ID: 12826264
[TBL] [Abstract][Full Text] [Related]
37. Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord.
Festoff BW; SantaCruz K; Arnold PM; Sebastian CT; Davies PJ; Citron BA
J Neurochem; 2002 May; 81(4):708-18. PubMed ID: 12065630
[TBL] [Abstract][Full Text] [Related]
38. Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
Zhang J; Lesort M; Guttmann RP; Johnson GV
J Biol Chem; 1998 Jan; 273(4):2288-95. PubMed ID: 9442073
[TBL] [Abstract][Full Text] [Related]
39. Endothelial cell-surface tissue transglutaminase inhibits neutrophil adhesion by binding and releasing nitric oxide.
Lai TS; Lindberg RA; Zhou HL; Haroon ZA; Dewhirst MW; Hausladen A; Juang YL; Stamler JS; Greenberg CS
Sci Rep; 2017 Nov; 7(1):16163. PubMed ID: 29170410
[TBL] [Abstract][Full Text] [Related]
40. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras.
Hettasch JM; Peoples KA; Greenberg CS
J Biol Chem; 1997 Oct; 272(40):25149-56. PubMed ID: 9312126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
